Equities

Scancell Holdings PLC

SCLP:LSE

Scancell Holdings PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)10.10
  • Today's Change0.00 / 0.00%
  • Shares traded211.83k
  • 1 Year change-33.20%
  • Beta1.1945
Data delayed at least 20 minutes, as of May 17 2024 16:39 BST.
More ▼

Financials data is unavailable for this security.

Cash flow in GBPView more

In 2023, cash reserves at Scancell Holdings PLC fell by 8.81m. However, Cash Flow from Investing totalled 81.00k, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 8.14m for operations while cash used for financing totalled 746.00k.
Cash flow per share-0.0128
Price/Cash flow per share--
Book value per share-0.0102
Tangible book value per share-0.0144
More ▼

Balance sheet in GBPView more

Scancell Holdings PLC has a Debt to Total Capital ratio of 173.03%, a higher figure than the previous year's 59.34%.
Current ratio8.63
Quick ratio--
Total debt/total equity--
Total debt/total capital1.73
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.